Psychotherapy For Children With Bipolar And Depressive Disorders

Packed with ready-to-use clinical tools, this book presents the first evidence-based psychological treatment for school-age children with bipolar disorder or depression. Leading clinician-researcher Mary Fristad and her colleagues show how to integrate psychoeducational strategies with cognitive-behavioral and family therapy techniques. They provide nuts-and-bolts information for implementing the approach with individual families or groups. Kids learn to identify and manage mood states while parents learn essential skills for problem solving, crisis management, improving family functioning, and collaborating with schools and mental health systems. In a large-size format with lay-flat binding for easy photocopying, the book features nearly 100 reproducible handouts and children's activities.

This book is a practical and authoritative guide to diagnosis and treatment of child and adolescent depression in various clinical settings, health care systems, and cultures. Emphasis is placed on evidence-based precepts for treatment. The contributors address current controversies surrounding the potential risks of medications in children and discuss other biological treatments and psychotherapies. Key take-home points are listed at the end of each chapter. Flow charts and tables summarize treatment recommendations, and tables summarize evidence of effectiveness and quality of evidence. Also included are lists of other resources for clinicians, patients, and families.

Since it first appeared on bookshelves, The Bipolar Child has made an indelible mark on the field of psychiatry and has become the resource that families rely upon. Now, with more than 200,000 copies sold, the first book about early-onset bipolar disorder is completely revised and expanded. Bipolar disorder—manic depression—was once thought to be rare in children. Now researchers are discovering not only that bipolar disorder can begin early in life, but that it is much more common than ever imagined. Yet the illness is often misdiagnosed and mistreated with medications that can exacerbate the symptoms. Why? Bipolar disorder manifests itself differently in children than in adults, and in children there is an overlap of symptoms with other childhood psychiatric disorders. As a result, these kids may be labeled with any of a number of psychiatric conditions: “ADHD,” “depression,” “oppositional defiant disorder,” “obsessive-compulsive disorder,” or “generalized anxiety disorder.” Too often they are treated with stimulants or antidepressants—medications that can actually worsen the bipolar condition. Since the publication of its first edition, The Bipolar Child has helped many thousands of families get to the root cause of their children’s behaviors and symptoms and find what they need to know. The Papoloses comprehensively detail the diagnosis, explain how to find good treatment and medications, and advise parents about ways to advocate effectively for their children in school. In this edition, a greatly expanded education chapter describes all the changes in educational law due to the 2004 reauthorization of IDEA (Individuals with Disabilities Education Act), and offers a multitude of ideas for parents and educators to help the children feel more comfortable in the academic environment. The book also contains crucial information about hospitalization, the importance of neuropsychological testing (with a recommended battery of tests), and the world of insurance. Included in these pages is information on promising new drugs, greater insight into the special concerns of teenagers, and additional sections on the impact of the illness on the family. In addition, an entirely new chapter focuses on major advances taking place in the field of molecular genetics and offers hope that researchers will better understand the illness and develop more targeted and easier-to-tolerate medicines. The Bipolar Child is rich with the voices of parents, siblings, and the children themselves, opening up the long-closed world of the families struggling with this condition. This book has already proved to be an invaluable resource for parents whose children suffer from mood disorders, as well as for the professionals who treat and educate them, and this new edition is sure to continue to light the way.

Since it first appeared on bookshelves, The Bipolar Child has made an indelible mark on the field of psychiatry and has become the resource that families rely upon. Now, with more than 200,000 copies sold, the first book about early-onset bipolar disorder is completely revised and expanded. Bipolar disorder—manic depression—was once thought to be rare in children. Now researchers are discovering not only that bipolar disorder can begin early in life, but that it is much more common than ever imagined. Yet the illness is often misdiagnosed and mistreated with medications that can exacerbate the symptoms. Why? Bipolar disorder manifests itself differently in children than in adults, and in children there is an overlap of symptoms with other childhood psychiatric disorders. As a result, these kids may be labeled with any of a number of psychiatric conditions: “ADHD,” “depression,” “oppositional defiant disorder,” “obsessive-compulsive disorder,” or “generalized anxiety disorder.” Too often they are treated with stimulants or antidepressants—medications that can actually worsen the bipolar condition. Since the publication of its first edition, The Bipolar Child has helped many thousands of families get to the root cause of their children’s behaviors and symptoms and find what they need to know. The Papoloses comprehensively detail the diagnosis, explain how to find good treatment and medications, and advise parents about ways to advocate effectively for their children in school. In this edition, a greatly expanded education chapter describes all the changes in educational law due to the 2004 reauthorization of IDEA (Individuals with Disabilities Education Act), and offers a multitude of ideas for parents and educators to help the children feel more comfortable in the academic environment. The book also contains crucial information about hospitalization, the importance of neuropsychological testing (with a recommended battery of tests), and the world of insurance. Included in these pages is information on promising new drugs, greater insight into the special concerns of teenagers, and additional sections on the impact of the illness on the family. In addition, an entirely new chapter focuses on major advances taking place in the field of molecular genetics and offers hope that researchers will better understand the illness and develop more targeted and easier-to-tolerate medicines. The Bipolar Child is rich with the voices of parents, siblings, and the children themselves, opening up the long-closed world of the families struggling with this condition. This book has already proved to be an invaluable resource for parents whose children suffer from mood disorders, as well as for the professionals who treat and educate them, and this new edition is sure to continue to light the way.

Every day can be an ordeal for families struggling with the difficult, moody, "impossible" behavior that may point to childhood depression or bipolar disorder. Effective help for kids does exist, but it often requires a customized combination of medication, therapy, coping skills, and support. From esteemed clinician and researcher Dr. Mary Fristad and fellow treatment expert Dr. Jill Goldberg Arnold, this indispensable book explains how treatment works and what additional steps parents can take at home to help children with mood disorders--and the family as a whole--improve the quality of their lives. Explained are why symptoms look so different (and can be so much harder to manage) in children and teens than in adults, how to find the right doctor or therapist, and how to help kids develop their own "coping toolkits." Bursting with practical tools, FAQs, and examples, the book covers everything from dealing with medical crises to resolving school problems, sibling conflicts, and marital stress.

Bipolar spectrum disorders are characterized by severe mood dysregulation, rage, irritability, and depression, along with low self-esteem and interpersonal struggles. Children with bipolar symptoms also tend to have poor academic performance and disruptive school behavior, and their families often experience strained relationships and increased conflict. RAINBOW: A Child- and Family-Focused Cognitive-Behavioral Treatment for Pediatric Bipolar Disorder presents a 12-session family-based treatment intervention for children aged 7-13 with bipolar spectrum disorders. The CFF-CBT/RAINBOW program comprises four innovative aspects in that it: (1) is designed to be developmentally specific to children in this age group; (2) is driven by the distinct needs of these children and their families; (3) involves intensive work with parents parallel to the work with children in order to directly address parents' own therapeutic needs, as well as helping them develop an effective parenting style for their child; and (4) integrates psychoeducation, cognitive-behavioral therapy, and interpersonal therapy techniques, tailored to the unique needs of these children, to augment the effects of pharmacotherapy. This Clinician Manual includes a conceptual overview for each session as well as step-by-step instructions for clinicians with all accompanying handouts, worksheets, and in-session games/activities. It provides clinicians with a comprehensive set of tools and a structured approach to guiding children and families. RAINBOW has been shown to significantly reduce mood symptoms and improve overall functioning for children with bipolar spectrum disorders.

Although research on the diagnosis and treatment of depression in children and adolescents has lagged far behind that in adults, recent large-scale studies -- armed with operationalized criteria and validated assessment instruments -- have done much to close this gap. In The Many Faces of Depression in Children and Adolescents, Drs. Shaffer and Waslick lead a distinguished group of contributors in presenting an overview of the key findings and concepts emerging from recent empirical efforts to understand the cause of depressive illness in youth. Featured are the following: Current findings regarding the epidemiology, diagnosis, and treatment of depression in childhood and adolescence Results of major clinical trials evaluating outpatient psychotherapeutic interventions for depressed and suicidal children and adolescents (e.g., cognitive-behavior therapy and interpersonal psychotherapy for depressed children and adolescents; dialectical behavior therapy for suicidal youth) State-of-the-art principles of pharmacotherapy for acute, continuation, and maintenance treatment phases of major depressive disorder in children and adolescents Dilemmas and challenges related to the diagnosis of bipolar disorder in children Current knowledge regarding the epidemiology and clinical manifestations of -- and the etiological risk factors for -- suicidal ideation, suicide attempts, and completed suicide Developments in the emerging field of youth suicide prevention An invaluable compendium of current thought on a disorder whose potential consequences can be nothing short of devastating, this volume belongs on the bookshelf of every clinician who treats children and adolescents.

Recent advances in evidence-based treatment of pediatric bipolar disorder are comprehensively reviewed in this authoritative volume. The prominent editors and contributors examine the current status of widely used medications and psychosocial therapies, and explore new horizons in tailoring treatment to individuals' neurobiological and clinical profiles. Chapters on specific populations discuss strategies for addressing common co-occurring disorders in children and adolescents with bipolar disorder, treating preschoolers, targeting depressive symptoms, and improving early intervention and prevention. Other essential topics include medication side effects and approaches to monitoring and ameliorating them, and ethical issues related to treatment and research.